Agios to Present New Clinical Data from its IDH Programs at ASCO

World News: . []

CAMBRIDGE Mass May 16 2018 GLOBE NEWSWIRE -- Agios Pharmaceuticals Inc NASDAQAGIO a leader in the field of cellular metabolism to treat cancer and rare genetic diseases today announced that new data from its isocitrate dehydrog enase (...

More news and information about Agios Pharmaceuticals, Inc.

Published By:

Globe Newswire: 22:02 GMT Wednesday 16th May 2018

Published: .

Search for other references to "agios" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us